INT52156

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.62
First Reported 1995
Last Reported 2005
Negated 1
Speculated 0
Reported most in Abstract
Documents 6
Total Number 6
Disease Relevance 0.40
Pain Relevance 2.01

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (SCG2) extracellular region (SCG2) intracellular (SCG2)
Anatomy Link Frequency
substantia nigra 1
entopeduncular nucleus 1
medial 1
Nasal 1
globus pallidus 1
SCG2 (Homo sapiens)
Pain Link Frequency Relevance Heat
Substantia nigra 3 99.96 Very High Very High Very High
Enkephalin 8 97.44 Very High Very High Very High
substance P 6 96.84 Very High Very High Very High
Nucleus accumbens 7 91.92 High High
amygdala 16 85.44 High High
Inflammation 2 76.76 Quite High
Peripheral nervous system 1 73.00 Quite High
Spinal cord 2 72.08 Quite High
Neuropeptide 12 71.88 Quite High
Calcitonin gene-related peptide 2 54.08 Quite High
Disease Link Frequency Relevance Heat
Increased Venous Pressure Under Development 3 83.84 Quite High
INFLAMMATION 2 76.76 Quite High
Urological Neuroanatomy 1 76.08 Quite High
Rhinitis 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Nasal capsaicin challenge produced local pain (P <0.05) and increased the levels of fucose (P <0.05), but failed to affect the levels of secretoneurin.
Neg (failed) Regulation (affect) of secretoneurin in Nasal
1) Confidence 0.62 Published 2005 Journal Allergy Section Body Doc Link 15727576 Disease Relevance 0 Pain Relevance 0
A high concentration of secretoneurin immunoreactivity was also observed in the central and medial amygdaloid nuclei.
Regulation (immunoreactivity) of secretoneurin in medial
2) Confidence 0.27 Published 1997 Journal Synapse Section Abstract Doc Link 9131771 Disease Relevance 0 Pain Relevance 0.41
Secretoneurin immunoreactivity was present in small- to medium-sized neurons of dorsal root and nodose ganglia.
Regulation (immunoreactivity) of Secretoneurin in ganglia
3) Confidence 0.26 Published 2000 Journal Neuroscience Section Abstract Doc Link 10619482 Disease Relevance 0.15 Pain Relevance 0.16
In the globus pallidus, entopeduncular nucleus, and substantia nigra, secretoneurin immunoreactivity was oriented ventromedially preferentially in woolly fibers.
Regulation (immunoreactivity) of secretoneurin in substantia nigra associated with substantia nigra
4) Confidence 0.25 Published 1995 Journal J. Comp. Neurol. Section Abstract Doc Link 7745136 Disease Relevance 0.08 Pain Relevance 0.48
In the globus pallidus, entopeduncular nucleus, and substantia nigra, secretoneurin immunoreactivity was oriented ventromedially preferentially in woolly fibers.
Regulation (immunoreactivity) of secretoneurin in entopeduncular nucleus associated with substantia nigra
5) Confidence 0.09 Published 1995 Journal J. Comp. Neurol. Section Abstract Doc Link 7745136 Disease Relevance 0.08 Pain Relevance 0.48
In the globus pallidus, entopeduncular nucleus, and substantia nigra, secretoneurin immunoreactivity was oriented ventromedially preferentially in woolly fibers.
Regulation (immunoreactivity) of secretoneurin in globus pallidus associated with substantia nigra
6) Confidence 0.09 Published 1995 Journal J. Comp. Neurol. Section Abstract Doc Link 7745136 Disease Relevance 0.08 Pain Relevance 0.48

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox